InvestorsHub Logo
Followers 84
Posts 32158
Boards Moderated 85
Alias Born 03/22/2005

Re: None

Sunday, 01/08/2017 10:40:36 AM

Sunday, January 08, 2017 10:40:36 AM

Post# of 1643
>>> Mymetics Corporation, a vaccine company, focuses on developing vaccines for infectious diseases primarily in Switzerland. The company?s product pipeline includes five proprietary vaccines in development for the prevention and treatment of human immunodeficiency virus type 1/AIDS, intra nasal influenza, malaria, herpes simplex virus type I and II, and respiratory syncitial virus vaccine. It has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative, and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland. <<<




Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.